Stevens offers online pharmaceutical project management course
New course deals with issues in managing pharmaceutical projects
HOBOKEN , N.J. — Stevens Institute of Technology’s WebCampus will offer a new course, Introductory Project Management for the Pharmaceutical Industry (MGT 609WP), during its spring term. The course was developed under the umbrella of Technogenesis® by The Wesley J. Howe School of Technology Management’s Project Management program, The Howe School’s Pharmaceutical Management program, The Charles V. Schaefer School of Engineering’s Pharmaceutical Manufacturing program and WebCampus. Registration is now open for this course, which begins on January 23, 2006 .
This online instructor-led, interdisciplinary course was created for prospective students in both management and engineering and can be applied to many Stevens’ masters programs and the MBA in Technology Management. It is one of many pharmaceutical-oriented courses offered under the WebPharma banner that are designed to appeal to industry professionals as well as those who want to enter the pharmaceutical industry.
The course deals with the problems of managing a project for the purpose of achieving a specific objective. Both operational and conceptual issues are considered. Operational issues include definition, planning, implementation, control and evaluation of the project. Conceptual issues include project management vs. hierarchical management, matrix organization, project authority, ethics, motivation and morale. Cases, examples and discussions relevant to the pharmaceutical industry illustrate problems in project management and how to resolve them.
Fernando Portes, the course instructor, has 17 years of experience in the pharmaceutical and medical devices industries. He has worked at Baxter, Merck, Johnson & Johnson and Wyeth. He managed technology transfer, validation, capital, process improvement, compliance, Six Sigma and procurement projects. He is a certified project management professional (PMP), a certified quality engineer (CQE) and is listed in Who’s Who in Science and Engineering. He is a member of the Project Management Institute (PMI), of the International Society for Pharmaceutical Engineering (ISPE) and of the Cornell Engineering Alumni Association (CEAA).
About Stevens Institute of Technology
Founded in 1870 and celebrating 140 Years of Innovation, Stevens Institute of Technology, The Innovation University, is one of the leading technological universities in the world dedicated to learning and research. Through its broad-based curricula, nurturing of creative inventiveness, and cross disciplinary research, the Institute is at the forefront of global challenges in engineering, science, and technology management. Partnerships and collaboration between, and among, business, industry, government and other universities contribute to the enriched environment of the Institute. A new model for technology commercialization in academe, known as Technogenesis®, involves external partners in launching business enterprises to create broad opportunities and shared value.
Stevens offers baccalaureates, master’s and doctoral degrees in engineering, science, computer science and management, in addition to a baccalaureate degree in the humanities and liberal arts, and in business and technology. The university has a total enrollment of 2,234 undergraduate and 3,700 graduate students with more than 400 faculty. Stevens’ graduate programs have attracted international participation from China, India, Southeast Asia, Europe and Latin America. Additional information may be obtained from its web page at www.stevens.edu.
For the latest news about Stevens, please visit StevensNewsService.com.
